Patent · US Active

Codon optimized recombinant phage and methods of using same

US10039795B2 · kind B2 · utility

0Cited by
2References
59Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 8, 2015
Grant dateAug 7, 2018
Priority date
Expiry dateJul 18, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2458/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Composition and methods for the detection of one or more target microbe(s) are provided. Compositions of the disclosure include at least one recombinant phage capable of infecting a target microbe, said phage comprising at least a capsid protein sequence, a ribosome binding site, and a codon-optimized marker. Compositions of the disclosure may further include an aqueous solution that enhances the ability to detect marker expression upon phage infection of the target microbe. In some embodiments the target microbe include is Listeria.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.